OncoSwab

OncoSwab

Private
CourrouxHealthcare & Life Scienceshttps://oncoswab.com

Last Round

Grant

May 5, 2025

Total Funding Raised

$2.2M

Momentum Score

50 /100

Company Overview

OncoSwab is a diagnostic equipment company developing a non-invasive, nasal swab-based test for the early detection of lung cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

lung cancer detectionnon-invasive diagnosticsnasal swab testliquid biopsylaboratory developed testLDTbiomarker analysislung nodule assessmentearly cancer detectioncancer screeningrisk stratificationdiagnostic servicepulmonology diagnosticsCLIA lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoSwab Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoSwab Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 5, 2025
Pre SeedOct 25, 2024

Key People

Founding team and executive leadership

Andrea Stephany Diaz

Co-Founder CEO

Founding Team

OncoSwab Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2025

    Secured $1.58M in grant funding.

OncoSwab Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoSwab Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoSwab's valuation, stock price, and market status.

Firmographic Details

HeadquartersCourroux
Employee Range7
Year Founded2023
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.